Brief: Reprocell Applies For Manufacturing & Marketing Approval In Japan For Stem Cell Therapy Stemchymal
24/06/2026 16:31
BRIEF-Reprocell Applies For Manufacturing & Marketing Approval In Japan For Stem Cell Therapy Stemchymal June 24 (Reuters) - ReproCell Inc 4978.T:
REPROCELL SUBMITS APPLICATION FOR MANUFACTURING AND MARKETING APPROVAL IN JAPAN FOR STEM CELL THERAPY STEMCHYMAL® FOR SPINOCEREBELLAR ATAXIA (SCA3 AND SCA6)
Source text: ID:nPreC8LgRa
Further company coverage: 4978.T
((Reuters.Briefs@thomsonreuters.com;))